Multiple Sclerosis (MS) is a demyelinating disease of the human central nervous system
having an unconfirmed pathoetiology. Although animal models are used to mimic the …

Multiple sclerosis (MS) is a neuroinflammatory disorder characterized by autoimmune-
mediated inflammatory lesions in CNS leading to myelin damage and axonal loss. MS is a …

A change in visual perception is a frequent early symptom of multiple sclerosis (MS), the
pathoaetiology of which remains unclear. Following a slow demyelination process caused …

Multiple sclerosis (MS) is an autoimmune neuroinflammatory disease where the underlying
mechanisms driving disease progression have remained unresolved. HLA-DR2b (DRB1 …

Molecular mimicry, a phenomenon in which microbial or environmental antigens resemble
host antigens, has been proposed as a potential trigger for autoimmune responses. In this …

Multiple sclerosis (MS) is characterized as an inflammatory demyelinating disease that
affects the central nervous system (CNS), leading to sensory, motor and cognitive …

This volume provides a comprehensive overview of recent advances in targeting glutamate
signaling for the treatment of major psychiatric and neurological disorders. It draws on the …

Multiple sclerosis (MS) is an autoimmune disease typified by overt demyelination and
inflammation that develop in selected regions of the central nervous system (CNS). Besides …

Multiple sclerosis (MS) is characterized as an inflammatory demyelinating disease that
affects the central nervous system (CNS), leading to sensory, motor and cognitive …

Multiple sclerosis (MS) is a progressive neurodegenerative disorder which occurs when
autoreactive T-lymphocytes infiltrate the central nervous system (CNS) and damage the …